Abbott Laboratories buy Royal Bank of Canada
Start price
25.01.24
/
50%
€102.54
Target price
25.01.25
€118.09
Performance (%)
-4.68%
Price
10.05.24
€97.22
Summary
This prediction is currently active. With a performance of -4.68%, the BUY prediction by Royal_Bank_of_Canada is trending in the wrong direction. A total of €0.52 was paid as dividends for this prediction. This prediction currently runs until 25.01.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Abbott Laboratories | -1.179% | -1.179% |
iShares Core DAX® | 4.094% | 3.543% |
iShares Nasdaq 100 | 1.424% | 0.512% |
iShares Nikkei 225® | -1.572% | -4.633% |
iShares S&P 500 | 1.822% | 0.963% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE: ABT) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $128.00 price target on the stock.
Ratings data for ABT provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€98.67
19.04.24
19.04.24
€117.41
19.04.25
19.04.25
-1.47%
10.05.24
10.05.24
Abbott Laboratories
Start price
Target price
Perf. (%)
€104.16
14.02.24
14.02.24
€119.35
14.02.25
14.02.25
-6.17%
10.05.24
10.05.24
Abbott Laboratories
Start price
Target price
Perf. (%)
€102.98
11.01.24
11.01.24
€116.90
11.01.25
11.01.25
-4.61%
10.05.24
10.05.24